| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.7M | — |
| R&D Expense | $182.4M | +25.3% |
| SG&A Expense | $122.1M | +100.3% |
| Operating Income | -$301.6M | -46.0% |
| Interest Expense | $15.7M | — |
| Income Tax | $0 | — |
| Net Income | -$311.5M | -50.9% |
| EPS (Basic) | -$5.66 | -35.4% |
| EPS (Diluted) | -$5.66 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.6M | -44.4% |
| Accounts Receivable | $8.5M | — |
| Inventory | $7.5M | — |
| Current Assets | $437.4M | +8.6% |
| Total Assets | $449.3M | +10.1% |
| Current Liabilities | $37.8M | +13.4% |
| Long-term Debt | $197.8M | +173.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$257.7M | -47.6% |
| Capital Expenditures | $333K | -66.5% |
| Investing Cash Flow | -$87.2M | -14.8% |
| Financing Cash Flow | $301.8M | +7.0% |
| Free Cash Flow | -$258.0M | -46.9% |
| Total Liabilities |
| $239.7M |
| +117.0% |
| Stockholders' Equity | $209.6M | -29.6% |